
|Videos|March 13, 2022
Dr. Gomella highlights his NYU GU 2022 presentations on bladder and prostate cancer
Author(s)Urology Times staff
“The fascinating thing is that we have so many new treatments that are now available to us,” says Leonard G. Gomella, MD, FACS.
Advertisement
In this video, Leonard G. Gomella, MD, FACS, discusses key points from his 2 presentations, “Monitoring and Diagnosis of Non—Muscle-Invasive Bladder Cancer,” and “The Evolution of Biomarkers and Genetics in the Management of Prostate Cancer,” which were given at the 15th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies. Gomella is the Bernard W. Godwin Professor of Prostate Cancer, chair of urology, and senior director for clinical affairs, Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants tentative approval to generic olaparib tablets across previously approved indications
2
Phase 3 trial launches of CAIX-targeted radiopharmaceutical for ccRCC
3
Published data support PSMA-PET–guided selection for 177Lu-rosopatamab tetraxetan in mCRPC
4
Prof Declan Murphy on interpreting the PROTEUS trial in localized prostate cancer
5











